Westgaard, A.; Pirnat, A.; Hjermstad, M.J.; Aass, N.; Kaasa, S.; Dajani, O.F.
Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter. Curr. Oncol. 2024, 31, 5462-5471.
https://doi.org/10.3390/curroncol31090404
AMA Style
Westgaard A, Pirnat A, Hjermstad MJ, Aass N, Kaasa S, Dajani OF.
Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter. Current Oncology. 2024; 31(9):5462-5471.
https://doi.org/10.3390/curroncol31090404
Chicago/Turabian Style
Westgaard, Arne, Aleksandra Pirnat, Marianne Jensen Hjermstad, Nina Aass, Stein Kaasa, and Olav Faisal Dajani.
2024. "Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter" Current Oncology 31, no. 9: 5462-5471.
https://doi.org/10.3390/curroncol31090404
APA Style
Westgaard, A., Pirnat, A., Hjermstad, M. J., Aass, N., Kaasa, S., & Dajani, O. F.
(2024). Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers—Simple Tools Matter. Current Oncology, 31(9), 5462-5471.
https://doi.org/10.3390/curroncol31090404
